Selected research
Industry Research
Digital Pathology Software Industry Research Report 2026
Market perspective
The global Digital Pathology Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digital Pathology Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digital Pathology Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digital Pathology Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digital Pathology Software include Roche, 3DHISTECH, Hamamatsu Photonics, ZEISS, OptraScan, Media Cybernetics, Visiopharm, Sectra and Digital Slide Archive, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digital Pathology Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digital Pathology Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digital Pathology Software Market by Company
Roche
3DHISTECH
Hamamatsu Photonics
ZEISS
OptraScan
Media Cybernetics
Visiopharm
Sectra
Digital Slide Archive
Aiforia
PathAI
Pathomation
Proscia
Indica Labs
Gestalt
Xybion
NovoPath
Glencoe Software
Orbit Image Analysis
Augmentiqs
Leica Biosystems
Olympus
Philips
Digital Pathology Software Segment by Type
Open-Source Platforms
Closed-Source Platforms
Digital Pathology Software Segment by Application
Pharmaceutical
Clinical Use
Research
Education
Digital Pathology Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digital Pathology Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Open-Source Platforms
- Closed-Source Platforms
Applications
- Pharmaceutical
- Clinical Use
- Research
- Education
Companies covered
- Roche
- 3DHISTECH
- Hamamatsu Photonics
- ZEISS
- OptraScan
- Media Cybernetics
- Visiopharm
- Sectra
- Digital Slide Archive
- Aiforia
- PathAI
- Pathomation
- Proscia
- Indica Labs
- Gestalt
- Xybion
- NovoPath
- Glencoe Software
- Orbit Image Analysis
- Augmentiqs
- Leica Biosystems
- Olympus
- Philips
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digital Pathology Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Open-Source Platforms
- 2.2.3 Closed-Source Platforms
- 2.3 Digital Pathology Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical
- 2.3.3 Clinical Use
- 2.3.4 Research
- 2.3.5 Education
- 2.4 Assumptions and Limitations
3 Digital Pathology Software Breakdown Data by Type
- 3.1 Global Digital Pathology Software Historic Market Size by Type (2021-2026)
- 3.2 Global Digital Pathology Software Forecasted Market Size by Type (2027-2032)
4 Digital Pathology Software Breakdown Data by Application
- 4.1 Global Digital Pathology Software Historic Market Size by Application (2021-2026)
- 4.2 Global Digital Pathology Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digital Pathology Software Market Perspective (2021-2032)
- 5.2 Global Digital Pathology Software Growth Trends by Region
- 5.2.1 Global Digital Pathology Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digital Pathology Software Historic Market Size by Region (2021-2026)
- 5.2.3 Digital Pathology Software Forecasted Market Size by Region (2027-2032)
- 5.3 Digital Pathology Software Market Dynamics
- 5.3.1 Digital Pathology Software Industry Trends
- 5.3.2 Digital Pathology Software Market Drivers
- 5.3.3 Digital Pathology Software Market Challenges
- 5.3.4 Digital Pathology Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digital Pathology Software Players by Revenue
- 6.1.1 Global Top Digital Pathology Software Players by Revenue (2021-2026)
- 6.1.2 Global Digital Pathology Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Digital Pathology Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digital Pathology Software Head Office and Area Served
- 6.4 Global Digital Pathology Software Players, Product Type & Application
- 6.5 Global Digital Pathology Software Manufacturers Established Date
- 6.6 Global Digital Pathology Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digital Pathology Software Market Size (2021-2032)
- 7.2 North America Digital Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digital Pathology Software Market Size by Country (2021-2026)
- 7.4 North America Digital Pathology Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digital Pathology Software Market Size (2021-2032)
- 8.2 Europe Digital Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digital Pathology Software Market Size by Country (2021-2026)
- 8.4 Europe Digital Pathology Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Pathology Software Market Size (2021-2032)
- 9.2 Asia-Pacific Digital Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digital Pathology Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digital Pathology Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digital Pathology Software Market Size (2021-2032)
- 10.2 South America Digital Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digital Pathology Software Market Size by Country (2021-2026)
- 10.4 South America Digital Pathology Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Pathology Software Market Size (2021-2032)
- 11.2 Middle East & Africa Digital Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digital Pathology Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digital Pathology Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche
- 12.1.1 Roche Company Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Revenue in Digital Pathology Software Business (2021-2026)
- 12.1.4 Roche Digital Pathology Software Product Portfolio
- 12.1.5 Roche Recent Developments
- 12.2 3DHISTECH
- 12.2.1 3DHISTECH Company Information
- 12.2.2 3DHISTECH Business Overview
- 12.2.3 3DHISTECH Revenue in Digital Pathology Software Business (2021-2026)
- 12.2.4 3DHISTECH Digital Pathology Software Product Portfolio
- 12.2.5 3DHISTECH Recent Developments
- 12.3 Hamamatsu Photonics
- 12.3.1 Hamamatsu Photonics Company Information
- 12.3.2 Hamamatsu Photonics Business Overview
- 12.3.3 Hamamatsu Photonics Revenue in Digital Pathology Software Business (2021-2026)
- 12.3.4 Hamamatsu Photonics Digital Pathology Software Product Portfolio
- 12.3.5 Hamamatsu Photonics Recent Developments
- 12.4 ZEISS
- 12.4.1 ZEISS Company Information
- 12.4.2 ZEISS Business Overview
- 12.4.3 ZEISS Revenue in Digital Pathology Software Business (2021-2026)
- 12.4.4 ZEISS Digital Pathology Software Product Portfolio
- 12.4.5 ZEISS Recent Developments
- 12.5 OptraScan
- 12.5.1 OptraScan Company Information
- 12.5.2 OptraScan Business Overview
- 12.5.3 OptraScan Revenue in Digital Pathology Software Business (2021-2026)
- 12.5.4 OptraScan Digital Pathology Software Product Portfolio
- 12.5.5 OptraScan Recent Developments
- 12.6 Media Cybernetics
- 12.6.1 Media Cybernetics Company Information
- 12.6.2 Media Cybernetics Business Overview
- 12.6.3 Media Cybernetics Revenue in Digital Pathology Software Business (2021-2026)
- 12.6.4 Media Cybernetics Digital Pathology Software Product Portfolio
- 12.6.5 Media Cybernetics Recent Developments
- 12.7 Visiopharm
- 12.7.1 Visiopharm Company Information
- 12.7.2 Visiopharm Business Overview
- 12.7.3 Visiopharm Revenue in Digital Pathology Software Business (2021-2026)
- 12.7.4 Visiopharm Digital Pathology Software Product Portfolio
- 12.7.5 Visiopharm Recent Developments
- 12.8 Sectra
- 12.8.1 Sectra Company Information
- 12.8.2 Sectra Business Overview
- 12.8.3 Sectra Revenue in Digital Pathology Software Business (2021-2026)
- 12.8.4 Sectra Digital Pathology Software Product Portfolio
- 12.8.5 Sectra Recent Developments
- 12.9 Digital Slide Archive
- 12.9.1 Digital Slide Archive Company Information
- 12.9.2 Digital Slide Archive Business Overview
- 12.9.3 Digital Slide Archive Revenue in Digital Pathology Software Business (2021-2026)
- 12.9.4 Digital Slide Archive Digital Pathology Software Product Portfolio
- 12.9.5 Digital Slide Archive Recent Developments
- 12.10 Aiforia
- 12.10.1 Aiforia Company Information
- 12.10.2 Aiforia Business Overview
- 12.10.3 Aiforia Revenue in Digital Pathology Software Business (2021-2026)
- 12.10.4 Aiforia Digital Pathology Software Product Portfolio
- 12.10.5 Aiforia Recent Developments
- 12.11 PathAI
- 12.11.1 PathAI Company Information
- 12.11.2 PathAI Business Overview
- 12.11.3 PathAI Revenue in Digital Pathology Software Business (2021-2026)
- 12.11.4 PathAI Digital Pathology Software Product Portfolio
- 12.11.5 PathAI Recent Developments
- 12.12 Pathomation
- 12.12.1 Pathomation Company Information
- 12.12.2 Pathomation Business Overview
- 12.12.3 Pathomation Revenue in Digital Pathology Software Business (2021-2026)
- 12.12.4 Pathomation Digital Pathology Software Product Portfolio
- 12.12.5 Pathomation Recent Developments
- 12.13 Proscia
- 12.13.1 Proscia Company Information
- 12.13.2 Proscia Business Overview
- 12.13.3 Proscia Revenue in Digital Pathology Software Business (2021-2026)
- 12.13.4 Proscia Digital Pathology Software Product Portfolio
- 12.13.5 Proscia Recent Developments
- 12.14 Indica Labs
- 12.14.1 Indica Labs Company Information
- 12.14.2 Indica Labs Business Overview
- 12.14.3 Indica Labs Revenue in Digital Pathology Software Business (2021-2026)
- 12.14.4 Indica Labs Digital Pathology Software Product Portfolio
- 12.14.5 Indica Labs Recent Developments
- 12.15 Gestalt
- 12.15.1 Gestalt Company Information
- 12.15.2 Gestalt Business Overview
- 12.15.3 Gestalt Revenue in Digital Pathology Software Business (2021-2026)
- 12.15.4 Gestalt Digital Pathology Software Product Portfolio
- 12.15.5 Gestalt Recent Developments
- 12.16 Xybion
- 12.16.1 Xybion Company Information
- 12.16.2 Xybion Business Overview
- 12.16.3 Xybion Revenue in Digital Pathology Software Business (2021-2026)
- 12.16.4 Xybion Digital Pathology Software Product Portfolio
- 12.16.5 Xybion Recent Developments
- 12.17 NovoPath
- 12.17.1 NovoPath Company Information
- 12.17.2 NovoPath Business Overview
- 12.17.3 NovoPath Revenue in Digital Pathology Software Business (2021-2026)
- 12.17.4 NovoPath Digital Pathology Software Product Portfolio
- 12.17.5 NovoPath Recent Developments
- 12.18 Glencoe Software
- 12.18.1 Glencoe Software Company Information
- 12.18.2 Glencoe Software Business Overview
- 12.18.3 Glencoe Software Revenue in Digital Pathology Software Business (2021-2026)
- 12.18.4 Glencoe Software Digital Pathology Software Product Portfolio
- 12.18.5 Glencoe Software Recent Developments
- 12.19 Orbit Image Analysis
- 12.19.1 Orbit Image Analysis Company Information
- 12.19.2 Orbit Image Analysis Business Overview
- 12.19.3 Orbit Image Analysis Revenue in Digital Pathology Software Business (2021-2026)
- 12.19.4 Orbit Image Analysis Digital Pathology Software Product Portfolio
- 12.19.5 Orbit Image Analysis Recent Developments
- 12.20 Augmentiqs
- 12.20.1 Augmentiqs Company Information
- 12.20.2 Augmentiqs Business Overview
- 12.20.3 Augmentiqs Revenue in Digital Pathology Software Business (2021-2026)
- 12.20.4 Augmentiqs Digital Pathology Software Product Portfolio
- 12.20.5 Augmentiqs Recent Developments
- 12.21 Leica Biosystems
- 12.21.1 Leica Biosystems Company Information
- 12.21.2 Leica Biosystems Business Overview
- 12.21.3 Leica Biosystems Revenue in Digital Pathology Software Business (2021-2026)
- 12.21.4 Leica Biosystems Digital Pathology Software Product Portfolio
- 12.21.5 Leica Biosystems Recent Developments
- 12.22 Olympus
- 12.22.1 Olympus Company Information
- 12.22.2 Olympus Business Overview
- 12.22.3 Olympus Revenue in Digital Pathology Software Business (2021-2026)
- 12.22.4 Olympus Digital Pathology Software Product Portfolio
- 12.22.5 Olympus Recent Developments
- 12.23 Philips
- 12.23.1 Philips Company Information
- 12.23.2 Philips Business Overview
- 12.23.3 Philips Revenue in Digital Pathology Software Business (2021-2026)
- 12.23.4 Philips Digital Pathology Software Product Portfolio
- 12.23.5 Philips Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst